The Obeticholic Acid Market is undergoing significant growth, fueled by the increasing global burden of liver-related disorders, particularly primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Obeticholic acid, a semi-synthetic bile acid analog, has emerged as a critical treatment for these chronic liver conditions, with growing demand witnessed across pharmaceutical and...